Cargando…
Current Perspectives On Emerging Biomarkers For Rheumatoid Arthritis-Associated Interstitial Lung Disease
Rheumatoid arthritis (RA) is a common systemic autoimmune disease whose fibro-inflammatory manifestations may affect a number of tissues and organs, including the lungs. In fact, interstitial lung disease (ILD) is a leading cause of mortality among patients with RA. RA-related interstitial lung dise...
Autores principales: | Amigues, Isabelle, Ramadurai, Deepa, Swigris, Jeffrey J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800546/ https://www.ncbi.nlm.nih.gov/pubmed/31686925 http://dx.doi.org/10.2147/OARRR.S166070 |
Ejemplares similares
-
Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
por: Mohning, Michael P., et al.
Publicado: (2021) -
Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis
por: Furukawa, Hiroshi, et al.
Publicado: (2021) -
Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease
por: Matama, Goushi, et al.
Publicado: (2023) -
Rheumatoid arthritis-associated interstitial lung disease
por: Solomon, Joshua J, et al.
Publicado: (2012) -
Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis–Associated Interstitial Lung Disease
por: Mena-Vázquez, Natalia, et al.
Publicado: (2023)